MedTrace Logo

Honest Open Proud for Adolescents With Mental Illness

NCT02751229 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-05-09

No results posted yet for this study

Summary

The purpose of the study is to evaluate the efficacy of the group-based intervention 'Honest Open Proud' among adolescents with mental illness.

Conditions

  • Secrecy Versus Disclosure Among Adolescents With Mental Illness

Interventions

BEHAVIORAL

Honest Open Proud (HOP)

five lessons in three modules, two for each two-hour session 1. Considering pros and cons of disclosing: * hurtful and helpful attitudes about mental illness * identify beliefs participants hold about themselves * explore five-step process to challenge their personally hurtful beliefs * weigh pros and cons of coming out in order to facilitate a decision on whether to disclose 2. Different ways to disclose: * different levels of (non-) disclosure and how to weigh the cons and pros * disclosure via social media versus disclosing face to face * how to find people that are better to disclose to than others and how to 'test them out' * participants will discuss how others might respond to their disclosure and how that will affect them 3. Telling your story: * how to tell one's story in a personally meaningful way, how to identify peers who might help with the coming out process, to review how telling one's story felt

Sponsors & Collaborators

  • Child and Adolescent Psychiatry Weissenau, Centre for Psychiatry in South-Württemberg, Germany

    collaborator UNKNOWN

  • Josefinum, Child and Adolescent Psychiatry and Psychotherapy, Augsburg, Germany

    collaborator UNKNOWN

  • Illinois Institute of Technology, Chicago, USA

    collaborator UNKNOWN

  • University of Ulm

    lead OTHER

Principal Investigators

  • Nicolas Rüsch, Professor · Department of Psychiatry II, Section Public Mental Health, Ulm University, Bezirkskrankenhaus Günzburg, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • United States
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02751229 on ClinicalTrials.gov